Shanghai Umibio Biotechnology Co., Ltd.
PrivateLast Round
Series B
Extension
Mar 30, 2021
Total Funding Raised
$27.01M
Company Overview
Shanghai Umibio Biotechnology Co., Ltd. operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a Series B Extension round in March 2021.
Shanghai Umibio Biotechnology Co., Ltd. is a biotechnology company that provides exosome research, services, and related reagent development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shanghai Umibio Biotechnology Co., Ltd. Comparables
Compare Shanghai Umibio Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Carrier Biomed (Suzhou) Co., Ltd. | 86% | |
| Beijing Echo Biotech Co., Ltd. | 84% | |
| CellBio Scientific | 80% |
For institutional investors. Book with your work email.
Shanghai Umibio Biotechnology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Mar 30, 2021 | ||||
| Series A | Oct 19, 2018 | ||||
| Angel | Mar 1, 2016 |
For institutional investors. Book with your work email.
Shanghai Umibio Biotechnology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Alwin Capital | Series A |
| Apricot Capital | Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 30, 2021
Raised $4.61M in a Series B Extension round.
- Oct 19, 2018
$7.2M round with Alwin Capital and Hainan Haiyao Co Ltd.
For institutional investors. Book with your work email.
Shanghai Umibio Biotechnology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Shanghai Umibio Biotechnology Co., Ltd.'s valuation, stock price, and market status.
Is Shanghai Umibio Biotechnology Co., Ltd. a public or private company?
Shanghai Umibio Biotechnology Co., Ltd. is a private company.
What is the current stock price of Shanghai Umibio Biotechnology Co., Ltd.?
Shanghai Umibio Biotechnology Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Shanghai Umibio Biotechnology Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Shanghai Umibio Biotechnology Co., Ltd. worth (valuation)?
Valuation information for Shanghai Umibio Biotechnology Co., Ltd. is not publicly available.
Can I buy Shanghai Umibio Biotechnology Co., Ltd. stock?
Shanghai Umibio Biotechnology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Shanghai Umibio Biotechnology Co., Ltd.'s last funding round?
Shanghai Umibio Biotechnology Co., Ltd.'s most recent funding round was Series B Extension on March 30, 2021.
Who are the main investors in Shanghai Umibio Biotechnology Co., Ltd.?
Key investors in Shanghai Umibio Biotechnology Co., Ltd. include Alwin Capital, Apricot Capital.
Will Shanghai Umibio Biotechnology Co., Ltd. IPO soon?
No public IPO plans have been announced for Shanghai Umibio Biotechnology Co., Ltd..
How can I track Shanghai Umibio Biotechnology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Shanghai Umibio Biotechnology Co., Ltd.'s shares on secondary markets.